How long should patients remain on lebrikizumab to achieve optimal long-term control of their atopic dermatitis symptoms?

Featuring Alexandra Golant, MD | Associate Professor of DermatologyProgram Director, Dermatology ResidencyDepartment of DermatologyIcahn School of Medicine at Mount SinaiNew York, NY | Published April 01, 2025